REPROS THERAPEUTICS INC. Business Finance Contracts & Agreements
24 Contracts & Agreements
- Escrow Agreements (1 contract)
- Registration Rights Agreements (1)
- Stock Agreements (10)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (7)
- Form of Escrow Agreement, by and among Allergan Sales, LLC, the Company and JPMorgan Chase Bank, N.A (Filed With SEC on December 12, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and Warberg Warrant Fund V, dated as of December 11, 2017 (Filed With SEC on December 12, 2017)
- REPROS THERAPEUTICS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMONSTOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. SERIES B WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)
- REPROS THERAPEUTICS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. SERIES B WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS, INC. 2,744,125 Shares of Common Stock Series A Warrants to Purchase 3,742,500Shares of Common Stock Series B Warrants to Purchase 2,495,000Shares of Common... (Filed With SEC on May 22, 2017)
- REPROS THERAPEUTICS INC. $10,000,000 of Common Stock ($0.001 par value per share) Equity Distribution Agreement (Filed With SEC on August 9, 2016)
- REPROS THERAPEUTICS INC. (a Delaware corporation) 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 24, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 12, 2012)
- SUBSCRIPTION AGREEMENT REPROS THERAPEUTICS INC. FOR UP TO 2,463,538 SHARES OF COMMONSTOCK (Filed With SEC on January 27, 2012)
- 690,000Units REPROSTHERAPEUTICS INC. Each Unit consisting of 4 Sharesof Common Stock and 3 SeriesA Warrants and 2.45 Series B Warrants UNDERWRITINGAGREEMENT (Filed With SEC on February 9, 2011)
- Exhibit1.1 []Units REPROSTHERAPEUTICS INC. Each Unit consisting of []Shares of Common Stock and []Series A Warrants and [] Series BWarrants UNDERWRITINGAGREEMENT (Filed With SEC on February 2, 2011)
- REPROSTHERAPEUTICS INC. $10,000,000of Common Stock ($0.001par value per share) Equity DistributionAgreement (Filed With SEC on February 19, 2010)
- AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 3, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on September 29, 2008)
- Underwriting Agreement (Filed With SEC on January 31, 2007)
- ZONAGEN, INC. 2004 STOCK OPTION PLAN (Filed With SEC on January 24, 2005)
- 4,000,000 ZONAGEN, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2005)
